3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Classical hematology
1
Conditions
Thrombocytopenia
5
Leukemia
3
Hematologic Diseases
3
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Venous Thromboembolism
1
Transfusion Reaction
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Motor Activity
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
87
fludarabine
74
Tacrolimus
45
fludarabine phosphate
44
Mycophenolic Acid
42
Whole-Body Irradiation
41
Busulfan
35
Melphalan
31
Antilymphocyte Serum
24
thymoglobulin
22
Methotrexate
22
Rituximab
21
Standard of Care
20
Sirolimus
20
Azacitidine
20
venetoclax
19
Thiotepa
19
Stem Cell Transplantation
18
Granulocyte Colony-Stimulating Factor
18
Practice Guidelines as Topic
16
Cytarabine
16
Nivolumab
15
Filgrastim
15
Dexamethasone
14
Cyclosporine
13
Bortezomib
13
Mesna
12
Peripheral Blood Stem Cell Transplantation
11
trametinib
10
Specimen Handling
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Hematologic Neoplasms
×
Platelet Transfusion
×
Clear all
NCT04454723
2024-03-05
PalliaQOL
University of Oklahoma
Phase NA
Completed
20 enrolled
NCT02074436
2022-07-19
PROBLEMA
Emory University
Phase 2
Terminated
29 enrolled
10 charts